Free Trial

Invesco Ltd. Lowers Holdings in Green Plains, Inc. $GPRE

Green Plains logo with Basic Materials background

Key Points

  • Invesco Ltd. has reduced its stake in Green Plains, Inc. by 66.7%, owning 339,208 shares after selling 680,921 shares in the first quarter.
  • Green Plains reported a loss with ($0.41) earnings per share for the last quarter, missing consensus estimates and showing a 10.7% year-over-year revenue decline.
  • Equities analysts have given mixed ratings for Green Plains, with an average target price of $8.83 and ratings ranging from "Buy" to "Underperform."
  • Five stocks we like better than Green Plains.

Invesco Ltd. reduced its stake in Green Plains, Inc. (NASDAQ:GPRE - Free Report) by 66.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 339,208 shares of the specialty chemicals company's stock after selling 680,921 shares during the quarter. Invesco Ltd. owned about 0.50% of Green Plains worth $1,645,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also bought and sold shares of GPRE. First Trust Advisors LP grew its position in Green Plains by 109.9% during the fourth quarter. First Trust Advisors LP now owns 69,810 shares of the specialty chemicals company's stock valued at $662,000 after acquiring an additional 36,555 shares during the last quarter. MetLife Investment Management LLC grew its position in Green Plains by 12.3% during the fourth quarter. MetLife Investment Management LLC now owns 41,436 shares of the specialty chemicals company's stock valued at $393,000 after acquiring an additional 4,550 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Green Plains by 49.6% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 73,292 shares of the specialty chemicals company's stock worth $695,000 after purchasing an additional 24,290 shares during the last quarter. Voya Investment Management LLC grew its holdings in shares of Green Plains by 97.5% in the fourth quarter. Voya Investment Management LLC now owns 41,645 shares of the specialty chemicals company's stock worth $395,000 after purchasing an additional 20,556 shares during the last quarter. Finally, Freestone Grove Partners LP bought a new position in shares of Green Plains in the fourth quarter worth approximately $219,000.

Green Plains Stock Up 2.3%

Green Plains stock traded up $0.24 on Thursday, hitting $11.04. 1,039,242 shares of the stock traded hands, compared to its average volume of 1,881,061. The company has a current ratio of 1.47, a quick ratio of 0.94 and a debt-to-equity ratio of 0.58. The firm has a market cap of $724.16 million, a P/E ratio of -4.58 and a beta of 1.22. The business's fifty day simple moving average is $8.22 and its 200 day simple moving average is $5.93. Green Plains, Inc. has a 1 year low of $3.14 and a 1 year high of $14.67.

Green Plains (NASDAQ:GPRE - Get Free Report) last announced its quarterly earnings data on Monday, August 11th. The specialty chemicals company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.13). The firm had revenue of $552.83 million for the quarter, compared to analysts' expectations of $578.18 million. Green Plains had a negative net margin of 6.34% and a negative return on equity of 13.65%. The business's quarterly revenue was down 10.7% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.38) EPS. As a group, sell-side analysts forecast that Green Plains, Inc. will post -0.5 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Bank of America restated an "underperform" rating and issued a $7.00 target price (up previously from $4.50) on shares of Green Plains in a report on Thursday, August 14th. Zacks Research upgraded shares of Green Plains to a "hold" rating in a report on Monday, August 11th. BMO Capital Markets cut their target price on shares of Green Plains from $8.00 to $7.00 and set a "market perform" rating on the stock in a report on Monday, May 12th. Finally, Oppenheimer upgraded shares of Green Plains from a "market perform" rating to an "outperform" rating and set a $14.00 target price on the stock in a report on Thursday, August 28th. Two equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Green Plains has an average rating of "Hold" and an average target price of $8.83.

Check Out Our Latest Report on Green Plains

Green Plains Profile

(Free Report)

Green Plains Inc produces low-carbon fuels in the United States and internationally. It operates through three segments: Ethanol Production, Agribusiness and Energy Services, and Partnership. The Ethanol Production segment produces ethanol, distillers grains, and ultra-high protein and renewable corn oil.

Further Reading

Institutional Ownership by Quarter for Green Plains (NASDAQ:GPRE)

Should You Invest $1,000 in Green Plains Right Now?

Before you consider Green Plains, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Plains wasn't on the list.

While Green Plains currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.